Latest News

News

GSK awarded malaria vaccine contract by UNICEF

The pharmaceutical company GSK was awarded a contract for the first supply of a malaria vaccine by UNICEF ...

Malawi’s cholera outbreak sustained through winter

The beginning of Malawi’s cholera outbreak in March 2022 came at the end of rainy season. A spokesperson ...

Bavarian Nordic capacity increased with US manufacturer

Bavarian Nordic announced in August 2022 that it had “entered into an agreement” with GRAM to expand capacity ...

UNITAID’s “Landscape” of tools and strategies

UNITAID published a report to examine the "tools and interventions” to prevent mother-to-child transmission of HIV, syphilis, hepatitis ...

UK’s first human Brucella canis case confirmed

The European Scientific Counsel Companion Animal Parasites called for compulsory testing of imported dogs after the UK’s first ...

WHO updates guidance for Tuberculosis response

In August 2022 the WHO announced new guidance to “support national strategic planning” for TB responses. This guidance ...

UK’s JCVI updates Covid-19 booster programme

In August 2022 the Joint Committee on Vaccination and Immunisation (JCVI) published advice on the boosters that will ...

White paper from IDT Biologika: oncolytic viruses

In a white paper for IDT Biologika Dr Heidi Trusheim and Trevor Broadt examine the process of developing ...

mRNA vaccine for cancer shows promise at Tufts University

A study in PNAS in August 2022 presented an mRNA vaccine for cancer that targets the lymph nodes ...

Avian influenza restrictions lifted in the UK

The UK’s Chief Veterinary Office, Professor Christine Middlemiss, is appealing to bird keepers to maintain enhanced biosecurity measures. ...

UK approves Moderna’s dual vaccine against Covid

The UK Medicines and Healthcare products regulatory Agency (MHRA) announced in August that it had approved Moderna’s bivalent ...

University partners find MND therapy potential

Researchers announced in August 2022 that they found evidence that the drug terazosin “protects against the death of ...

White paper from IDT Biologika: viral vectors

In a white paper Dr Neubert explores how viral vectors offer a host of opportunities for vaccine development ...

Study reveals Covid-19 vaccinations safe for pregnancy

A study published in The Lancet in August 2022 concluded that Covid-19 vaccinations had a “good safety profile”. ...

CEPI driving research into monkeypox vaccines

In July CEPI announced that it would provide $375,000 to “support the development of key laboratory tools to ...

Professor Hotez warns against anti-vaccine activism

In August 2022 Dr Peter Hotez wrote an article in Nature exploring the dire consequences of America’s “anti-vaccine ...

Langya (LayV) henipavirus emerges in China

Langya (LayV) is a henipavirus. According to an article in New Scientist it appears to be “most closely ...

The monkeypox vaccine: how much do we know?

As monkeypox cases across the world continue to increase, rollouts of the one licensed vaccine are under pressure. ...

Tired T-cells need TLC to continue fighting cancer

When providing an immune response to cancer T-cells are known to get “exhausted” to the point of no ...

Pan-coronavirus vaccine hopes boosted by cold immunity

Scientists at La Jolla Institute for immunology have concluded that patients with a stronger immune response to the ...

Positive partnerships for malaria prevention

Malaria threatens almost half of the world’s population, with the WHO estimating that the number of deaths in ...

AI turns its sights to drug discovery challenges

The WHO states that cancer is a “leading cause of death worldwide”. It accounted for nearly 1 in ...

Climate health is global health, study concludes 

In August 2022 a study published in Nature concluded that 58% of infectious diseases that we face have ...

Lyme disease vaccine candidate proceeds to Phase III study

Lyme disease is a systemic infection transmitted to humans by infected ticks. It is caused by the Borrelia ...

Immune system map uncovers therapeutic potential

A group of scientists, led by researchers at the Wellcome Sanger Institute and ETH Zurich, created a “comprehensive ...

Improving protein factories for gene therapies

Gene therapy tackles the source of disease in the patient’s DNA through viral or bacterial vectors. Most commonly, ...

UKHSA under vaccine pressure as monkeypox continues

LGBTQ+ groups across a spectrum of political parties wrote to the Health and Social Care Secretary Steve Barclay ...

Antimicrobial resistant bacteria discovered in new-borns

A study published in Nature Microbiology in 2022 explored the links between the presence of antimicrobial resistant bacteria ...

Emerging emergencies require top authority

In July 2022 the Director-General of the WHO, Dr Tedros Adhanom Ghebreyesus, declared monkeypox to be a Public ...

Monkeypox doses stretched to the limit by NIH scientists

As global cases of monkeypox continue to increase, it is evident that vaccine demand is greater than the ...

Vertex’s “Fantasy project” with Moderna pushes CF limits

Vertex Pharmaceuticals and Moderna announced in 2022 their collaboration aimed at the “discovery and development of lipid nanoparticles ...

Experimental RSV vaccine promise shown in mice

The respiratory syncytial virus (RSV) infects almost all children before they turn 2 years old. The pathogen causes ...

“Shot to the heart” (of mutating viruses)

As the Covid-19 pandemic continues in myriad variants, current vaccine technology is struggling to keep up. Often employing ...

2030 AIDS elimination goals for new WHO alliance

The recent UNAIDS report revealed that only 52% of children with HIV are receiving life-saving treatment. This number ...

Gavi’s reasons to be optimistic: routine rises

After woeful statistics of global vaccine uptake, and the news that the AIDS response is “under threat”, GAVI ...

Science suggests components for pandemic disruption treaty

WHO member states can expect an update from an Intergovernmental Negotiating Body in August on an "initial draft" ...

Continuing the Covid-19 fight with monoclonal antibodies

As the Covid-19 pandemic continues sweeping across the globe, variants mutate and rise against current treatments. Protection afforded ...

Hear from our WVC 2022 speaker: Dr Jennifer Nuzzo

DrPh Jennifer Nuzzo, Professor at Brown University School of Public Health warned that the world is not ready ...

WHO’s new infection guidelines for “key populations”

In July 2022 the WHO published new guidelines on “HIV, viral hepatitis, and STI prevention, diagnosis, treatment, and ...

Northern Europe’s novel hepatitis nightmare

In April 2022 cases of acute hepatitis of “unknown origin” in children were reported across the WHO European ...

Hear from our WVC 2022 speaker: Dr David Kaslow

Dr David Kaslow, CSO of PATH, suggested the success of vaccines against future pandemics relied on leaders developing ...

Hear from our WVC 2022 speaker: Dr James Crowe

Dr Crowe, Director of the Vanderbilt Vaccine Centre and presenter at the World Vaccine Congress explained discoveries in ...

Twist Bioscience turns to monkeypox controls

Twist Bioscience has launched two monkeypox synthetic DNA controls that are estimated to provide 80% coverage of the ...

Back to the past: Polio pops up again in 2022

Although unrelated vaccine-like polio is found in the UK sewage every year, recent samples were different to the ...

Prioritising pathogens in a pandemic world

The WHO list of priority diseases sets out the diseases and pathogens that research and development in “public ...

Solving supply chain safety and sustainability concerns

As we experience healthcare crisis after healthcare crisis the need for safe and sustainable supply chains is more ...

Vaccine inequity strikes Africa once again

It appears that the clear lessons from the Covid-19 pandemic have been blatantly ignored, certainly regarding vaccine distribution. ...

Demanding sustainable subscriptions for AMR

An article by Drs Till Boularte and Ulrik Schilze of BCG stated that “when market forces fail to motivate ...

China’s antiviral pill: from HIV to Covid-19

In July 2022 China’s drug regulator gave conditional approval for Azvduine, an HIV drug developed by Genuine Biotech, ...

Operation Warp Speed is a wrap: farewell to funding

In typical American fashion (no offence – we're all just envious...) the US Covid-19 vaccination programme took the ...

Rabies results from Oxford University trial

On 28th July 2022 researchers from the University of Oxford reported positive results from a Phase I clinical ...

Danger ahead! The forgotten pandemic: AIDS

The warning from UNAIDS released in July 2022 featured an alarming front cover, with the words “in danger” ...

Together against Alzheimer’s: where do we stand?

Some of the most common indicators of Alzheimer’s disease include build-ups of beta-amyloid plaques, tau proteins, and neuroinflammation. ...

Vaccine fatigue: are we nearly there yet?

We’ve pushed against vaccine hesitancy, encouraged increased uptake of dose after dose, booster after dose. Booster after booster. ...

A universally acknowledged flu requires a universal vaccine

Literary references aside, flu is about as universal a truth as it gets; each year ‘flu season’ rears ...

Marburg virus: more to come or a fleeting moment?

A WHO Collaborating Centre in Senegal confirms from two samples that Ghana is experiencing its first outbreak of ...

Expecting the unexpected: preparing for Disease X

Of the 1.67 million viruses on the planet, scientists know of about 0.04%. Between 631,000 and 827,000 are ...

AMR – global problems require diagnostic solutions

AMR was declared by the WHO to be one of the top 10 global health threats to humanity, ...

Noses to the grindstone for nasal vaccines

Writing in Science in July 2022 Dr Eric Topol and Dr Akiko Iwasaki reflected on the “unprecedented success” ...

Clinical tribulations – how can we grow from Covid-19?

Clinical trials are a critical stage in development, and during the Covid-19 pandemic we watched vaccines hurtle through ...

VIE: looking back to last year’s winners!

The World Vaccine Congress in Washington DC, April 2022, was a resounding success with record numbers of attendees ...

A helping hand from double, double toil and trouble

Audiuvare – to help. Calling to mind a group of earnest lab assistants, the word adjuvant describes ingredients ...

Vaccines: more than just a “sharp scratch”?

When most of us think of vaccines we have visions of a nurse with a sharp needle, homing ...

High hopes for collaborative HIV vaccine development

In March 2022 Dr Anthony Fauci, director of NIAID, reflected that developing an effective HIV vaccine is a ...

Diabetes developments, Provention and Diamyd

Historic diabetes treatment focuses on treating the condition with insulin, but recent immunotherapies have been moving to delay ...

Does EBV hold the key for Multiple Sclerosis?

Multiple Sclerosis (MS) affects the central nervous system in among 2.8 million people worldwide, yet the underlying cause ...

Fighting hidden threats: vaccines against cancer? 

Vaccines provide the immune system with information to recognise and fight threats before they appear in the body. ...

Global vaccine uptake: low, slow, room to grow

The Covid-19 pandemic has swept across the world with impunity over the past three years, bringing to light ...

Me before you before us: vaccine nationalism

The word stockpiling marked its place the public vocabulary thanks to its increased used during the Covid-19 pandemic. ...

Why are covid vaccinations in pregnant women so low?

The Covid-19 pandemic presented the scientific community with one of the fastest changing challenges of the 21st century. ...

Marking World Hepatitis Day, 28th July 2022

World Hepatitis Day is on July 28th, marking the birthday of Dr Baruch Blumberg, the Nobel-prize winning scientist ...
vaccine hesitancy solutions

Fighting fear with facts or feelings? Vaccine hesitancy.

In our previous article on vaccine hesitancy, we identified the ‘5Cs’ associated with a reluctance or refusal to ...
monkeypox

Monkeypox matters – preventing the next pandemic?

In May 2022, Monkeypox cases in non-endemic countries were reported, with 1,856 confirmed cases in the UK as ...
vaccine hesitancy

Immune to the science? The ‘5C’ drivers of vaccine hesitancy

Vaccine hesitancy is described by SAGE as a “delay in acceptance or refusal of vaccines despite availability of ...
MOST POPULAR THIS MONTH